Effect of inhibitor binding on the 1H-15N HSQC spectra of RGS4.

Slides:



Advertisements
Similar presentations
IB Chemistry Topic B – Biochem
Advertisements

HIV-1 protease molecular dynamics of a wild- type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site.
Molecular Dynamics and Normal Mode Analysis of WW domain Santanu Chatterjee 1, Christopher Sweet 1, Tao Peng 2, John Zintsmaster 2, Brian Wilson 2, Jesus.
Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid (Y. Li, Z. Zhou, and C. B. Post) Richard S. L. Stein CS 379a.
Chapter 3 DRUG TARGETS: ENZYMES.
What are physically-reasonable methods for modeling macromolecules? How do we use analyze the data? How do we add more physics and mathematics into biological.
Folding of Distinct Sequences into Similar Functional Topologies Hossein Mohammadiarani and Harish Vashisth (Advisor) Department of Chemical Engineering,
Enzymes. A. Are Proteins (usually) that speed up metabolic reactions by lowering the activation energy. A. Some chemical reactions will occur spontaneously,
Ser Glu His Candida rugosa lipase: closed state (1TRH ) Glu His Ser Candida rugosa lipase: open state (1CRL) Catalytic Triad Abstract Lipases are extracellular.
Introduction. Zn 2+ homeostasis is regulated at the transcriptional level by the DNA-binding protein SmtB. Manipulation of Zn 2+ homeostasis could act.
Enzymes AP Biology. General Information Globular proteins Unique 3 dimensional shape Active site: pocket or groove where substrate binds.
Do Now 12/1 12 /1 Enzyme Inhibitors notes 22
 Spontaneous chemical reactions occur without a need for outside energy but may be very slow  Free energy: Δ G  Catalyst : a chemical agent that speeds.
Methods and Software NAMD (NAnoscale Molecular Dynamics) is a parallel molecular dynamics code designed for high performance simulation of large systems.
Understanding RNA Structure and Function using Molecular Dynamics Simulations ________________________________________________________________________________________________________________________________.
Mechanism of Curcumin Inhibiting Amyloid-  Peptides Aggregation by Molecular Dynamics Simulations Zhenyu Qian, and Guanghong Wei State Key Laboratory.
A Computational Study of RNA Structure and Dynamics Rhiannon Jacobs and Dr. Harish Vashisth Department of Chemical Engineering, University of New Hampshire,
A Computational Study of RNA Structure and Dynamics Rhiannon Jacobs and Harish Vashisth Department of Chemical Engineering, University of New Hampshire,
Structural Bioinformatics Elodie Laine Master BIM-BMC Semester 3, Genomics of Microorganisms, UMR 7238, CNRS-UPMC e-documents:
Parastou Sadatmousavi§, & Ross C. Walker*
PROTEINS AS DRUG TARGETS:
SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH))
Ultrafast studies of resonance energy
INFERENCE OF PERSONALIZED DRUG TARGETS VIA NETWORK PROPAGATION
examples of Gibbs free energy calculations
Control of Metabolic Pathways (2)
Origin of Cooperativity
Cell Physiology: Metabolism
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Metabolic Pathways A metabolic pathway begins with a specific molecule and ends with a product Each step is catalyzed by a specific enzyme- importance.
Paper Introduction 29th September 2015.
AN INTRODUCTION TO METABOLISM
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Factors affecting enzyme activity
Modeling Nitrogen Metabolism in Yeast
Using Enhanced Sampling and Structural Restraints to Refine Atomic Structures into Low-Resolution Electron Microscopy Maps  Harish Vashisth, Georgios.
AP Biology Serrano High School
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Driven Adiabatic Dynamics Approach to the Generation of Multidimensional Free-Energy Surfaces. Mark E. Tuckerman, Dept. of Chemistry, New York University,
Enzymes and Glycolysis Talk about it Essentially, burning oil and cellular respiration are the same reaction. Why do you think there are so many.
Ligand Docking to MHC Class I Molecules
ION CHANNELS AS DRUG TARGETS &
Metabolism 8.1.
Some examples of how NMR can provide information about biological systems.
Do Now 12/4 12 /4 Enzyme Inhibitors notes 30 WOD: FRAY (fray) n.
ENZYME Enzymes as organic catalysts. Factor affecting enzyme activity.
Miquel Duran-Frigola, Roberto Mosca, Patrick Aloy  Chemistry & Biology 
Predicting the Signaling State of Photoactive Yellow Protein
Volume 13, Issue 9, Pages (December 2015)
Rishi Rakhit, Raul Navarro, Thomas J. Wandless  Chemistry & Biology 
“DFG-Flip” in the Insulin Receptor Kinase Is Facilitated by a Helical Intermediate State of the Activation Loop  Harish Vashisth, Luca Maragliano, Cameron F.
Thomas H. Schmidt, Yahya Homsi, Thorsten Lang  Biophysical Journal 
Enzymes and Metabolism
2.5 - Enzymes.
Unmasking the Annexin I Interaction from the Structure of Apo-S100A11
Paper Introduction By, Amrutha A.S..
Vinculin Activation Is Necessary for Complete Talin Binding
Atomistic Simulations of Viral Insulin Like and Insulin Mimetic Peptides Evan Redfearn and Dr. Harish Vashisth Department of Chemical Engineering, University.
Associations of hDAT with substrate proteins
Conformational Changes and Signaling in Cell and Matrix Physics
Enzyme Control of Metabolism
Structure and Interactions of PAS Kinase N-Terminal PAS Domain
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
General Animal Biology
Julia Salas Case Study, CS379a
General Animal Biology
The NorM MATE Transporter from N
Presentation transcript:

Effect of inhibitor binding on the 1H-15N HSQC spectra of RGS4. Allosteric Targeting of Protein-Protein Interactions Harish Vashisth (harish.vashisth@unh.edu; +1-603-862-2483) Department of Chemical Engineering—University of New Hampshire—Durham, NH SUPPORT: National Science Foundation CHE—1508595 ABSTRACT RESULTS: Atomistic Simulations of RGS4 Structures in Apo and Liganded States Intermolecular interactions are central to all cellular processes as many diseases can be directly linked to aberrant interactions between a pair of molecules, which makes it essential to design drugs that can reverse such malignant biophysical processes. Among these several protein-protein interactions (PPIs) represent critical therapeutic targets, but designing potent inhibitors to directly block such interactions remains significantly challenging. These challenges stem from difficulty in overcoming the binding energy associated with PPIs by a small molecule and targeting the large, relatively featureless interaction interfaces that commonly lack well-defined pockets into which small molecules can be targeted. Therefore, targeting allosteric sites may provide greater specificity and importantly remove the need to compete with the protein binding partner. In this work, we present the mechanism of action of one such allosteric inhibitor of an intracellular regulator of G-protein signaling protein that was investigated using atomistic simulations and NMR studies. Particularly, we find that the binding of inhibitor to a buried cysteine residue perturbs the protein-protein interface via an allosteric mechanism. MOTIVATION: Inhibition of Protein-Protein Interactions Classical (MD) and enhanced sampling (TAMD; temperature-accelerated molecular dynamics) simulations of apo-RGS4 MD equilibration of TAMD-generated states of RGS4. Data with and without inhibitor are shown. Change in root-mean-squared-fluctuations (ΔRMSF) on binding of CCG-50014 RESULTS: NMR vs. MD Simulation Analysis of Residue Perturbations RESULTS: Allosteric Inhibition of RGS4-Gα Protein-Protein Interaction BACKGROUND: RGS4 vs. RGS8 RGS4 CCG-50014 RGS8 CCG-50014: cysteine-specific inhibitor CCG-50014: over 20-fold more selective for RGS4 CCG-50014: RGS4 IC50 30nM Q1: How does inhibitor access buried cysteine residues--mechanism? Q2: What are molecular origins of selectivity difference? Hypothesis: Flexibility in helices facilitates inhibitor access CONCLUSIONS ACKNOWLEDGEMENTS Conformational change in α5-α6 helical bundle allows access to buried cysteine residue Inhibitor binding perturbs residues in RGS-Gα interface allosterically Inhibitor can spontaneously access buried cysteine in conformationally-open states of RGS4 and RGS8 We thank Prof. Rick Neubig (Michigan State University) for a fruitful collaboration on NMR studies. Effect of inhibitor binding on the 1H-15N HSQC spectra of RGS4. Perturbed residues are mapped for RGS4: Measured (NMR experiments) and Computed (MD runs)